	Can Blood Cell Count-Based Inflammatory Markers Reflect the Risk of Osteoporosis? A Cross-Sectional and Genetic Analysis. Immun Inflamm Dis Jin J, Yu C, Chen F, Li J, Zhu Y, Gao Y, Wang J, Ni F, Yao R, Chen S, Yu B, Lu Y, Huang K, Wu K. PMID: 42011028 [PubMed - as supplied by publisher]
	Association between baseline lipid levels and re-fracture after percutaneous vertebroplasty for osteoporotic vertebral compression fractures: a retrospective cohort study. J Orthop Surg Res Long Y, Kang W, Yao T, Lin X, Xu W. PMID: 42010664 [PubMed - as supplied by publisher]
	SuperLearner approach for predicting imminent risk of fracture in older Chinese patients with newly diagnosed osteoporosis based on their routine blood test markers. BMC Musculoskelet Disord Chen B, Zhang J, Fang Y, Liu C, Chen M. PMID: 42010589 [PubMed - as supplied by publisher]
	Pathophysiology, diagnosis and management of secondary osteoporosis. Nat Rev Endocrinol Paccou J, Tsourdi E, Anastasilakis AD, Lems WF, Compston J. PMID: 42010026 [PubMed - as supplied by publisher]
	Serum Insulin-like Growth Factor-1 and Growth Hormone as Potential Diagnostic Biomarkers for Postmenopausal Osteoporosis Among Chinese Women. J Vis Exp Su H, Zhao Q, Wu Z, Deng W, Wang J, Zhao B. PMID: 42008416 [PubMed - indexed for MEDLINE]
	Comparison of KN012, a denosumab biosimilar, versus reference denosumab in Chinese postmenopausal women with osteoporosis: efficacy, safety, and population pharmacokinetics in a 12-month phase III study. Bone Rep Zhu X, Liu J, Mao Y, Li J, Shao F, Lin H. PMID: 42006557 [PubMed]
	The osteoporosis diagnosis and treatment gaps among Iranian women aged 50 years and older. J Diabetes Metab Disord Shahrousvand S, Ostovar A, Fahimfar N, Khalagi K, Hesari E, Mansourzadeh MJ, Mansournia MA, Sanjari M. PMID: 42005855 [PubMed - as supplied by publisher]
	Comparison of Unilateral and Bilateral Percutaneous Vertebroplasty for Osteoporotic Vertebral Compression Fractures: A Prospective Observational Comparative Study. Cureus Reddy P, Biradar R, Nayak A. PMID: 42005146 [PubMed - as supplied by publisher]
	Romosozumab for the treatment of thalassemia-associated osteoporosis in two female patients. JBMR Plus Yavropoulou MP, Koloutsou ME, Delaporta P, Makras P, Anastasilakis AD, Kassi E, Kattamis A, Xekouki P. PMID: 42004613 [PubMed]
	A metabolomics-driven machine learning model for osteoporosis risk prediction. JBMR Plus Qiu C, Afolabi BL, Deng J, Su K, Jiang L, Gonzalez-Ramirez M, Mungasavalli Gnanesh SS, Luo Z, Tian Q, Shen H, Deng HW. PMID: 42004610 [PubMed - as supplied by publisher]
	Microvascular complications and risk of osteoporosis and fractures in type 2 diabetes: a nationwide Asian cohort study. J Endocrinol Invest Yen YH, Wei JC, Ko FS, Yen FS, Lin HJ, Li PY, Cho DY, Hwu CM, Hsu CC. PMID: 42002671 [PubMed - as supplied by publisher]
	Plasma proteins mediate the protective association between physical activity and osteoporosis risk: A prospective study in the UK biobank. Arch Gerontol Geriatr Liu B, Luo S, Geng Z, Jia X, Wang H, Pei Z, Tang T, Yang X, Zhang G, Zhang S, Zhang L. PMID: 42001538 [PubMed - as supplied by publisher]
	"One-stop-shop" medical imaging for osteoporosis and obese patients: a narrative review. J Endocrinol Invest Zhang L, Lei H, Li Y, Yang H, Zhao H. PMID: 41999439 [PubMed - as supplied by publisher]
	Romosozumab Versus Teriparatide for the Treatment of Postmenopausal Osteoporosis: An Overview of Systematic Reviews With Direct and Indirect Meta-Analyses. Int J Rheum Dis Bandeira TFGS, Aguiar PM, Vianna CMM, Mosegui GBG, Lima TM. PMID: 41999058 [PubMed - indexed for MEDLINE]
	Cost-effectiveness of osteoporotic fracture risk assessment in people with intellectual disabilities: a UK NHS modelling study. BMJ Open Png ME, Frighi V, Holt TA, Achana F, Smith MC, Collins GS, Roast J, Petrou S. PMID: 41997706 [PubMed - indexed for MEDLINE]
	Effect of a one time guideline based educational video intervention on osteoporosis related knowledge. Arch Orthop Trauma Surg Hauser AL, Noriega Urena JF, Saatashvili L, Esmail F, Lange T, Schulte TL, von Glinski A. PMID: 41995877 [PubMed - in process]
	Romosozumab versus teriparatide for risk of dementia in individuals with osteoporosis: a target trial emulation study. Osteoporos Int Hatano M, Okada A, Sasabuchi Y, Kimura Y, Sato S, Ishikura H, Tanaka T, Saito T, Tanaka S, Yasunaga H. PMID: 41995806 [PubMed - as supplied by publisher]
	Increased osteoporosis burden and comparative antiresorptive effectiveness in inflammatory bowel disease: a real-world cohort study. Osteoporos Int Desai A, Khataniar H, Habib H, Hashash JG, Farraye FA, Regueiro M, Long M, Kochhar GS. PMID: 41995805 [PubMed - as supplied by publisher]
	Comparative efficacy and safety of antiresorptive and anabolic therapies for male osteoporosis: an updated Bayesian network meta-analysis. Front Endocrinol (Lausanne) Li Z, Zhang L, Xue C, Lu C, Wang L. PMID: 41993988 [PubMed - indexed for MEDLINE]
	Therapeutic potential of natural products from Traditional Chinese Medicine in the treatment of osteoporosis. Front Pharmacol Xiao W, Liu W, Wang X, Zeng Q, Tang Y, Xia M, Dong L, Fei S, Yue W, Li S, Ouyang W. PMID: 41988518 [PubMed]

Articles 1 - 20 / 35563

Page 1 of 1779



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy